Top 30 Pharmaceutical Companies in Massachusetts

5 min read

Get started

Trusted by data-driven investors

Massachusetts is home to a thriving pharmaceutical industry, with leading companies pushing the boundaries of drug discovery and biopharmaceutical advancements. From cannabinoid-based therapies by Targeted Pharmaceuticals in Worcester to oncology-focused innovations by TESARO in Waltham, these firms are at the forefront of cutting-edge research in personalized medicine and biotech. Investment opportunities abound in sectors such as oncology, neurology, and antimicrobial resistance, driven by Massachusetts' robust ecosystem of publicly traded companies and dynamic startups.

VDA Pharma, Inc.

🇺🇸 108 MARLBOROUGH ST Boston, Massachusetts 02116, us

VDA Pharma, Inc. specializes in the manufacturing of biopharmaceuticals focused on HIV treatment, leveraging innovative approaches to develop effective therapies in the pharmaceutical industry.

pharmaceuticals
biopharmaceuticals
HIV
manufacturing
drug development
healthcare
biotechnology
therapeutics
Company size: 2-10
Founded: 2011
ARIAD Pharmaceuticals, Inc. logo

ARIAD Pharmaceuticals, Inc.

🇺🇸 26 Landsdowne Street Cambridge, Massachusetts 02139, US

ARIAD Pharmaceuticals specializes in pharmaceutical manufacturing with a focus on oncology and innovative drug development, leveraging biotechnology to advance cancer treatments.

pharmaceutical
biotech
biotechnology
oncology
cancer
drug development
Company size: 201-500
Founded: 1991
Targeted Pharmaceuticals logo

Targeted Pharmaceuticals

🇺🇸 60 Prescott St Worcester, Massachusetts 01605, US

Targeted Pharmaceuticals specializes in cannabinoid-based drug discovery and personalized medicine within the pharmaceutical manufacturing industry, focusing on innovative approaches to developing tailored therapeutic solutions.

cannabinoids
pharmaceuticals
marijuana
drug
discovery
medicine
targeted
personalized
therapies
treatments
cannabis
biopharmaceuticals
innovation
research
development
formulations
clinical
efficacy
dosage
extraction
Company size: 2-10
Founded: 2018
Samyang Biopharm USA logo

Samyang Biopharm USA

🇺🇸 600 One Kendall Square Suite 202

Specializing in biotechnology research, Samyang Biopharm USA focuses on out-licensing innovative nucleic acid drug delivery systems and aims to establish partnerships and co-development ventures with pharmaceutical firms in the U.S.

biotechnology
drug delivery
nucleic acid
biopharmaceuticals
out-licensing
partnerships
joint ventures
research
Company size: 2-10
Founded: 2018
Mispro logo

Mispro

🇺🇸 Cambridge, Ma, US

Mispro specializes in providing AAALAC-accredited contract vivarium services for preclinical rodent studies, catering to biopharmaceutical research organizations with comprehensive animal care and compliance solutions. Its innovative approach includes offering dedicated vivarium space and specialized services that enhance the efficiency of biomedical and pharmaceutical research.

vivarium
preclinical
animal care
compliance
biomedical
pharmaceutical
laboratory animals
drug development
in-vivo
husbandry
AAALAC
IACUC
Company size: 11-50
Founded: 2003
BioXchange logo

BioXchange

🇺🇸 Kendall Square Boston, MA 02139, US

BioXchange is a leading networking organization in the biotechnology research sector, focused on connecting individuals and companies within the life sciences community through specialized events. It leverages its extensive network to foster collaboration across various industry sectors, including pharmaceuticals and drug discovery.

networking
biotechnology
pharmaceuticals
life sciences
drug discovery
research
drug development
biotech
Company size: 2-10
Founded: 2018
NeuForm Pharmaceuticals, Inc. logo

NeuForm Pharmaceuticals, Inc.

🇺🇸 1661 Worcester St., Suite 102 Framingham, MA 01701, US

NeuForm Pharmaceuticals specializes in innovative drug discovery within the biopharmaceutical sector, developing proprietary and patent-protected candidates targeting oncology, neurology, immunology, and metabolic diseases. The organization emphasizes collaboration with top academic and clinical experts to deliver best-in-class medicines to patients.

biopharmaceuticals
drug discovery
oncology
neurology
immunology
metabolic diseases
clinical research
patent protection
innovative therapies
academic collaboration
Company size: 2-10
Founded: 2014
Arsanis logo

Arsanis

🇺🇸 Winter Street Waltham, MA 02451, US

Arsanis specializes in biotechnology research, focusing on innovative solutions in the pharmaceutical sector. The firm is positioned for growth following its merger with X4 Pharmaceuticals, enhancing its capabilities in developing advanced therapeutic options.

biotechnology
research
pharmaceuticals
mergers
drug development
Company size: 11-50
Founded: 2010
Tufts Center for the Study of Drug Development logo

Tufts Center for the Study of Drug Development

🇺🇸 145 Harrison Ave Boston, Massachusetts 02111, US

An independent, academic research center focused on enhancing the quality and efficiency of pharmaceutical and biopharmaceutical development, regulation, and utilization through strategic information and innovative research. It serves as a vital resource for stakeholders in the industry, regulatory agencies, and public policy, while fostering dialogue on critical issues affecting drug development globally.

pharmaceutical
biopharmaceutical
research
regulation
drug development
public policy
innovation
economic analysis
therapeutic agents
information resource
stakeholder engagement
strategic information
Company size: 11-50
Founded: 1976
Atea Pharmaceuticals, Inc logo

Atea Pharmaceuticals, Inc

🇺🇸 225 Franklin St Suite, 2100

Atea Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on discovering and developing innovative antiviral therapies for COVID-19 and severe viral diseases, addressing critical unmet medical needs in the biotechnology research industry.

biotechnology
pharmaceuticals
antiviral
clinical-stage
drug discovery
viral diseases
therapeutics
medical research
COVID-19
healthcare
Company size: 51-200
Founded: 2014
Anthos Therapeutics logo

Anthos Therapeutics

🇺🇸 55 Cambridge Pkwy 103

Anthos Therapeutics is a clinical-stage biopharmaceutical entity dedicated to developing and commercializing innovative therapies for cardiovascular and metabolic diseases, leveraging a unique blend of biotech agility and pharmaceutical rigor.

biotechnology
biopharmaceutical
clinical research
cardiovascular
metabolic diseases
innovative therapies
drug development
commercialization
genetic validation
pharmacological validation
Company size: 11-50
Ra Pharmaceuticals logo

Ra Pharmaceuticals

🇺🇸 87 Cambridgepark Dr Cambridge, Massachusetts 02140, US

Ra Pharmaceuticals specializes in pharmaceutical manufacturing, focusing on innovative therapies for rare diseases. Its unique approach includes the development of peptide-based treatments, enhancing the effectiveness and precision of drug delivery.

pharmaceuticals
manufacturing
biotechnology
drug development
therapeutics
life sciences
clinical trials
Company size: 5001-10000
Prilenia logo

Prilenia

🇺🇸 Boston, Massachusetts, US

Prilenia is a clinical-stage biotechnology firm dedicated to developing innovative treatments for neurodegenerative and neurodevelopmental disorders, with a focus on its lead asset, Pridopidine, a first-in-class oral drug candidate. The firm is actively conducting advanced clinical trials for Huntington’s disease and ALS, leveraging an established safety profile to address significant unmet medical needs.

biotechnology
research
neurodegenerative
neurodevelopmental
treatments
clinical trials
drug development
oral drugs
Huntington’s disease
ALS
movement disorders
safety profile
Company size: 11-50
Founded: 2018
Javelin Biotech logo

Javelin Biotech

🇺🇸 299 Washinton St Woburn, MA- MASSACHUSETTS 01801, US

Javelin Biotech specializes in biotechnology research, developing predictive drug discovery platforms that integrate human and computational biology to enhance preclinical drug discovery and increase drug approval rates.

biotechnology
drug discovery
predictive modeling
computational biology
preclinical research
human biology
drug approval
Company size: 11-50
CKP Therapeutics, Inc. logo

CKP Therapeutics, Inc.

🇺🇸 110 Canal Street Lowell, MA 01852, US

CKP Therapeutics is a biotechnology research firm dedicated to developing innovative molecules and combination therapies aimed at treating metastatic cancer and overcoming drug resistance. Its research-intensive approach positions it at the forefront of cancer therapeutics.

biotechnology
cancer
therapeutics
research
drug resistance
combination therapies
pharmaceuticals
metastatic cancer
Company size: 2-10
Founded: 2019
Accellient Partners, LLC logo

Accellient Partners, LLC

🇺🇸 1000 Winter Street, Suite 2000 Waltham, MA, US

Accellient Partners specializes in biotechnology research, offering integrated drug development services that encompass regulatory consulting, project management, and compliance support. Their innovative approach minimizes risks and costs while accelerating development timelines, making them a preferred partner for biopharmaceutical and investment firms navigating the complex drug development landscape.

drug development
regulatory consulting
biopharmaceutical
FDA submissions
IND submission
program management
nonclinical development
risk assessment
capital raising
manufacturing support
milestone achievement
investment strategy
Company size: 2-10
Founded: 2010
PharmaEssentia logo

PharmaEssentia

🇺🇸 35 Corporate Drive Suite 325

PharmaEssentia specializes in biotechnology research, focusing on the development of innovative biologics for hematology, oncology, and immunology, with a commitment to improving patient outcomes in rare and orphan diseases. Its unique approach combines deep scientific expertise with a dedication to advancing drug development in the biopharmaceutical sector.

biotechnology
research
biologics
oncology
rare disease
orphan drugs
drug development
pharmaceuticals
hematology
immunology
Company size: 201-500
Founded: 2003
Wild Biotech logo

Wild Biotech

🇺🇸 Boston, US

Wild Biotech is a biotechnology research firm specializing in drug discovery, leveraging innovative approaches to develop resilient therapeutic solutions.

biotechnology
drug discovery
research
pharmaceuticals
healthcare
innovation
therapeutics
Company size: 2-10
Founded: 2019
Synspira Therapeutics, Inc. logo

Synspira Therapeutics, Inc.

🇺🇸 10 Speen St 302

Engaged in biotechnology research, Synspira Therapeutics focuses on innovative therapeutic solutions, emphasizing advancements in treatment methodologies.

biotechnology
research
therapeutics
pharmaceuticals
drug development
clinical trials
Company size: 2-10
Founded: 2017
Eloxx Pharmaceuticals logo

Eloxx Pharmaceuticals

🇺🇸 480 Arsenal Way Suite 130 Watertown, Massachusetts 02472, US

Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical firm specializing in the development of innovative RNA-modulating drug candidates aimed at treating rare and ultra-rare diseases caused by premature stop codons. Their lead product, ELX-02, is designed to enhance protein synthesis by enabling ribosomes to bypass these genetic mutations, addressing significant challenges in conditions like cystic fibrosis and cystinosis.

biotechnology
pharmaceuticals
rare
diseases
drug
development
elx-02
rna
therapeutics
healthcare
small molecule
cystic fibrosis
cystinosis
read-through
mutations
proteins
clinical
research
biopharma
investigational
Company size: 11-50
Founded: 2013
EIP PHARMA, INC logo

EIP PHARMA, INC

🇺🇸 20 Park Plaza Suite 424

CervoMed is a clinical-stage therapeutics firm specializing in the development of CNS-focused treatments for neurodegenerative diseases, leveraging a robust development pipeline to advance innovative solutions in the pharmaceutical manufacturing industry.

pharmaceutical
manufacturing
CNS
therapeutics
neurodegenerative
clinical-stage
drug development
healthcare
biopharmaceutical
innovation
Company size: 2-10
Founded: 2014
NeuroCores, Inc. logo

NeuroCores, Inc.

🇺🇸 201 Washington St. #2600

NeuroCores, Inc. is a preclinical-stage biopharmaceutical firm specializing in the development of treatments for rare pediatric neurological and neurodegenerative disorders. Its innovative approach includes the use of plasmalogen derivatives, which exhibit strong anti-neuroinflammatory and neurogenesis effects, positioning the firm as a leader in addressing critical unmet medical needs in this niche market.

biotechnology
research
biopharmaceutical
pediatric
neurological disorders
neurodegenerative diseases
drug development
clinical studies
anti-neuroinflammatory
neurogenesis
orphan drug
rare diseases
Company size: 2-10
TESARO, Inc. logo

TESARO, Inc.

🇺🇸 1000 Winter St Waltham, Massachusetts 02451, US

TESARO is an oncology-focused biopharmaceutical firm dedicated to enhancing the cancer care experience through innovative drug development and commercialization. Their mission emphasizes a patient-first approach, fostering a culture of unconditional care and commitment to advancing oncology treatments.

pharmaceuticals
oncology
biopharmaceuticals
drug development
drug commercialization
cancer care
Company size: 501-1000
Immunocan logo

Immunocan

🇺🇸 625 Massachusetts Ave Cambridge, Massachusetts 02139, US

Immunocan specializes in biotechnology research, focusing on innovative gene-edited animal platforms for the discovery of fully human and alpaca antibodies, enhancing antibody drug R&D across diverse scenarios.

biotechnology
gene editing
antibody discovery
drug development
research platform
animal models
human antibodies
alpaca antibodies
Company size: 51-200
Founded: 2021
Trevie Research logo

Trevie Research

🇺🇸 245 First Street Riverview II 18th Floor

Trevie Research specializes in oncology-focused clinical development and trial management, offering expert advisory services in biopharma drug development and commercialization. The firm leverages extensive experience and strong relationships with key opinion leaders to support Phase I/II drug development programs for biotech, pharmaceutical, and non-profit organizations.

biotechnology
oncology
clinical development
trial management
biopharma
drug development
commercialization
trial operations
Phase I
Phase II
KOLs
academia
Company size: 11-50
Founded: 2014
Novelion Therapeutics logo

Novelion Therapeutics

🇺🇸 Boston, US

Novelion Therapeutics focuses on developing innovative biopharmaceuticals aimed at establishing new standards of care for rare diseases, with a diverse portfolio that includes treatments for metabolic disorders and ongoing research into therapies for inherited retinal diseases. Their commitment to advancing science and clinical development distinguishes them in the biotechnology research industry.

biopharmaceutical
rare diseases
clinical development
gene therapy
retinal disease
drug development
therapeutic portfolio
biotechnology research
Company size: 201-500
Dyax logo

Dyax

🇺🇸 55 Network Drive Burlington, MA 01803, US

Dyax specializes in biotechnology research, focusing on innovative approaches to develop therapies for rare diseases. Its expertise in this niche area enhances its contributions to the biotechnology industry.

biotechnology
research
pharmaceuticals
drug development
clinical trials
therapeutics
genetic engineering
Company size: 51-200

Aurora Biopharma, Inc.

🇺🇸 ONE MIFFLIN PL Cambridge, Massachusetts 02138, us

Aurora Biopharma, Inc. specializes in research services within the biopharmaceutical industry, focusing on innovative approaches to drug development and therapeutic solutions.

research
biopharma
clinical trials
pharmaceuticals
biotechnology
drug development
medical research
Company size: 11-50
Founded: 2015
Oxeia Biopharmaceuticals Inc logo

Oxeia Biopharmaceuticals Inc

🇺🇸 361 Newbury St Boston, Massachusetts 02115, US

Oxeia Biopharmaceuticals is focused on developing innovative therapeutics for mild traumatic brain injury (concussion) and related neuro-metabolic dysfunction, with a clinical-stage drug, OXE103, currently undergoing Phase 2 trials. Their unique approach addresses a significant gap in treatment options for concussion patients, emphasizing the need for more than just rest.

biotechnology
therapeutics
clinical trials
mild traumatic brain injury
neuro-metabolic dysfunction
concussion
drug development
Company size: 2-10
Founded: 2014
Augment Biologics logo

Augment Biologics

🇺🇸 Cambridge, MA, US

Augment Biologics is engaged in biotechnology research, focusing on leveraging advancements in glycobiology to innovate and enhance biologic drug development.

glycobiology
biologics
drug development
biotechnology
research
Company size: 1

Updated on

Let our AI browse all websites for you

Save time, improve accuracy, and get ahead of the competition with Cenco.ai.

Get started

You might be interested in